Høeg’s appointment to director of the FDA's CDER follows a turbulent period for the department, which has seen five leaders ...

The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...

The commissioners’ concerns are in response to sweeping vaccine regulation changes earmarked by CBER head Vinay Prasad.

Formosa Pharmaceuticals and Rxilient Medical have agreed on the commercialisation of APP13007 in ASEAN markets.

Eli Lilly and Company has received approval from the US FDA for the expanded use of Jaypirca tablets in 100mg and 50mg doses.